22157.jpg
Lupus Nephritis Dug Pipeline Landscape Report : Therapeutic Assessment by 2024 by Product Type, Stage, Route of Administration, and Molecule Type
November 22, 2024 06:50 ET | Research and Markets
Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Lupus Nephritis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.The report outlays comprehensive...
22157.jpg
Lupus Nephritis Market Insights and Forecast Report 2032 Explores US Dominance and Emerging Therapeutics
February 07, 2024 04:33 ET | Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Lupus Nephritis - Market Insight, Epidemiology and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The global...
22157.jpg
Lupus Nephritis Drug Pipeline Research Report 2023: Comprehensive Insights about 20+ Companies and 25+ Pipeline Drugs
October 04, 2023 10:23 ET | Research and Markets
Dublin, Oct. 04, 2023 (GLOBE NEWSWIRE) -- The "Lupus Nephritis - Pipeline Insight, 2023" clinical trials has been added to ResearchAndMarkets.com's offering.This "Lupus Nephritis - Pipeline...
Logo.png
Lupus Nephritis Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Lupus Pipeline Comprising a Broad Spectrum of Molecular Targets
July 19, 2021 20:10 ET | DelveInsight Business Research LLP
Las Vegas, USA, July 19, 2021 (GLOBE NEWSWIRE) -- Lupus Nephritis Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Lupus Pipeline Comprising a Broad Spectrum of Molecular Targets ...